Latest filing published 01 Mar 2006 for VIROPHARMA INC, €156k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Baker Biotech Capital III (Z) (GP), LLC: trading record in brief
Baker Biotech Capital III (Z) (GP), LLC discloses dealings in 2 companies, chiefly Viropharma Inc and Intrabiotics Pharmaceuticals Inc /DE. Between 24 February 2006 and 28 February 2006, the trades on record add up to 7 filings.
The open-market side counts 1 purchase for €24k alongside 6 sales for €666k. Taken together, the sales exceed the purchases by €642k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 1 March 2006: an open-market sale of €156k, in Viropharma Inc. The clock since the last published purchase (28 February 2006) now reads 7,559 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Baker Biotech Capital III (Z) (GP), LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,500 shares@ US$21.743Common StockSEC:0001144204-06-008354:0
- 8,602 shares@ US$21.7242Common StockSEC:0001144204-06-008354:1
- 1,928 shares@ US$21.5799Common StockSEC:0001144204-06-008354:2
- 36 shares@ US$21.8063Common StockSEC:0001144204-06-008354:3
- 12,616 shares@ US$19.8953Common StockSEC:0001144204-06-008354:4
- 6,203 shares@ US$20.4109Common StockSEC:0001144204-06-008354:5
- 8,631 shares@ US$3.35Common StockSEC:0001144204-06-007969:0Canonical exit: 25 May 2006 (T+90)
7 of 7 declarations